Hepapac

Hepapac

Manufacturer:

Pacific Pharma (Korea)

Distributor:

AA Medical
Concise Prescribing Info
Contents
Biphenyl-dimethyl dicarboxylate
Indications/Uses
Supportive treatment of liver cell injury caused by virus or chemical substances.
Dosage/Direction for Use
1 softcap tds. May be increased to 2 softcap tds if necessary. Duration of therapy: 6-12 mth.
Contraindications
Special Precautions
Chronic active hepatitis & cirrhosis. Pregnancy & lactation.
Adverse Reactions
Xerostomia, nausea, skin rash, transient jaundice.
Drug Interactions
MIMS Class
Cholagogues, Cholelitholytics & Hepatic Protectors
ATC Classification
A05BA - Liver therapy ; Used in liver therapy.
Presentation/Packing
Form
Hepapac softcap 3 mg
Packing/Price
9 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in